Symet Labs Profile
Key Indicators
- Authorised Capital ₹ 3.50 M
as on 13-12-2024
- Paid Up Capital ₹ 3.50 M
as on 13-12-2024
- Company Age 27 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.79 M
as on 13-12-2024
- Satisfied Charges ₹ 4.35 M
as on 13-12-2024
- Revenue %
(FY 2020)
- Profit -27.28%
(FY 2020)
- Ebitda -360.00%
(FY 2020)
- Net Worth -1.68%
(FY 2020)
- Total Assets 0.47%
(FY 2020)
About Symet Labs
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 3.50 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹0.79 M. The company has closed loans amounting to ₹4.35 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Karusala and Srinivasa Nannamuri serve as directors at the Company.
- CIN/LLPIN
U24230TG1997PTC026236
- Company No.
026236
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Jan 1997
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Medak, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Symet Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Karusala  | Managing Director | 05-Oct-1998 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Nannamuri | Director | 18-May-2007 | Current |
Financial Performance of Symet Labs.
Symet Labs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 27.28% decrease in profit. The company's net worth dipped by a decrease of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Symet Labs?
In 2017, Symet Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Winrex Pharmaceuticals Private LimitedActive 28 years 3 monthsSrinivasa Nannamuri is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 01 Aug 2000 | ₹0.49 M | Open |
Punjab National Bank Creation Date: 03 Mar 2000 | ₹0.30 M | Open |
Andhra Pradesh State Financial Corporation Creation Date: 26 Dec 2008 | ₹2.35 M | Satisfied |
How Many Employees Work at Symet Labs?
Symet Labs has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Symet Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Symet Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
